Liquidia Technologies Appoints Dr. Thomas Templeman, Senior Vice President
Liquidia Technologies Inc. announced it has appointed Dr. Thomas Templeman as the company’s Senior Vice President, Integrated Supply Chain. Liquidia is a leader in the development of rationally designed nanoparticles for delivery of small molecule and biological agents to enable breakthroughs in vaccines, inhaled therapeutics, and siRNA-based therapeutics.
Dr. Templeman comes to Liquidia from Centocor Biologics, an operating company of Johnson & Johnson and manufacturing site that supports the Centocor family of biologic products. As General Manager, Dr. Templeman was responsible for establishing, managing, and updating regulated production facilities, including the implementation of operational and quality control systems.
Following his Postdoctoral Fellowship in Harvard University’s Department of Cellular and Developmental Biology in 1989, Dr. Templeman gained extensive experience in R&D and manufacturing processes at Vysis, Imagenetics, Gene-Trak, Ortho Clinical Diagnostics and most recently at Centocor Biologics. Dr. Templeman’s areas of expertise include the management of technical operations and the development, scale-up, and improvement of R&D processes to production output levels.
Other news from the department people
These products might interest you
Eclipse by Wyatt Technology
FFF-MALS system for separation and characterization of macromolecules and nanoparticles
The latest and most innovative FFF system designed for highest usability, robustness and data quality
DynaPro Plate Reader III by Wyatt Technology
Screening of biopharmaceuticals and proteins with high-throughput dynamic light scattering (DLS)
Efficiently characterize your sample quality and stability from lead discovery to quality control
